Current Research Studies
Cancer - NANT 2017-01: Phase I Study of 131I-MIBG with Dinutuximab for Relapsed/Refractory Neuroblastoma
What is the goal of this study?
The goal of this study is to determine how the combination of 131I-MIBG works with dinutuximab in patients with neuroblastoma.
Who can join the study?
This study may be a good fit for children and young adults who
- Are 1 to 30 years old and
- Have been diagnosed with neuroblastoma
What will happen if my child takes part in this study?
You can read more about this study on clinicaltrials.gov.
Who can I contact for more information?
To learn more, call 206-987-2106 or email the study coordinator.
